Luminist LabsAcquired
Luminist Labs was a diagnostic platform for early detection of liver disease [1] based in New York City, NY, USA [2]. The company went through Y Combinator in the Winter 2016 batch [3] and operated with a team size of 2 [4]. Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH) [5]. The company was acquired in 2020 by DiscernDx [6].
About
- Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.[5]
Something wrong or missing? Send a correction. Fixed within 24 hours.